Tracing (r)bST in cattle: Liquid-based options for extraction and separation by Regal López, Patricia et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ljlc20
Download by: [University of Santiago de Compostela] Date: 13 June 2017, At: 07:43
Journal of Liquid Chromatography & Related
Technologies
ISSN: 1082-6076 (Print) 1520-572X (Online) Journal homepage: http://www.tandfonline.com/loi/ljlc20
Tracing (r)bST in cattle: Liquid-based options for
extraction and separation
Patricia Regal, Alexandre Lamas, Cristina A. Fente, Carlos M. Franco &
Alberto Cepeda
To cite this article: Patricia Regal, Alexandre Lamas, Cristina A. Fente, Carlos M. Franco &
Alberto Cepeda (2017): Tracing (r)bST in cattle: Liquid-based options for extraction and separation,
Journal of Liquid Chromatography & Related Technologies, DOI: 10.1080/10826076.2017.1331453
To link to this article:  http://dx.doi.org/10.1080/10826076.2017.1331453
Accepted author version posted online: 19
May 2017.
Submit your article to this journal 
Article views: 30












, Cristina A. Fente
1








Department of Analytical Chemistry, Nutrition and Bromatology; Faculty of Veterinary 
Science, Universidade de Santiago de Compostela (Spain) 
 





Growth hormone (GH) or somatotropin (ST) is a species-specific polypeptide hormone 
produced in the pituitary gland of vertebrates. When administered exogenously to dairy 
cattle it has galactopoietic effects and is capable of increasing the milk yield. The 
beginning of the commercial production of recombinant variants of bovine somatotropin 
(rbST), by the end of the twentieth century, had a major economic impact in the dairy 
industry. Recombinant bST enabled large scale applications in farms, enhancing 
significantly milk production. While it is banned in the European Union (EU), several 
countries permit the trade and use of recombinant somatotropins in animal husbandry. 
Also, rbST-free dairy products can be frequently found in the market of those countries, 
even though these labels are not actually verified in a laboratory. In this context, effective 
analytical methods are needed for residue control to avoid an illegal use of rbST but also 
to prevent fraudulent labelling in some cases. The present review includes studies 
published in the last five years (from 2012 to 2017) to monitor rbST in bovine animals, 
using liquid-based applications. It is then intended to serve as a practical guide to help 
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1. INTRODUCTION TO (R) BST HORMONE 
Growth hormone (GH) or somatotropin (ST) belongs to the group of peptide and protein 
hormones. This single-chain polypeptide is secreted by the anterior pituitary in all 
vertebrates and exerts a wide range of biological activities including growth, energy 
metabolism, sexual maturation and immunity. It has two highly conserved disulfide 
bonds in its molecule, which are the key for its biological activity in animals. GH action 
is initiated by binding to membrane-bound receptors that are located at various tissues, 






Early research at the beginning of the 20th century in Russia and England found that milk 
production in cattle could be enhanced using pituitary extracts containing bST thanks to 
the ability of this hormone to coordinate and control bovine metabolism and nutrient 
partitioning. It was in the 1980s when it became economically and technically feasible to 
produce large quantities of pure hormone using recombinant DNA biotechnology, 
resulting in what is known as recombinant bST or rbST 
[2,3]
. The galactopoietic potency 
of different molecular variants of pituitary and recombinant bST were evaluated by 
Monsanto Agricultural Company in 1992 with a group of fifty four lactating Holstein 
cows 
[4]
. The animals receiving intramuscular injections of different forms of ST showed 
a greater response to recombinant variants than to pituitary molecules. In this context, 
rbST was approved for the first time for its use in the US by the Food and Drug 
Administration (FDA Agency) in 1993. This new product was released with the name of 
Posilac®, and it has played a significant role in the industrialization of US dairy 
production. FDA determined that the drug is safe for the treated animals and the animal 
products are safe for humans, hence the product is effective 
[5]
. Monsanto’s company 
licensed Eli Lilly to market its product in countries other than the US. The other two 
companies that developed recombinant versions of bST, Upjohn and American 
Cyanamid, no longer exist due to mergers and/or acquisitions by other companies.  
 
The administration of exogenous somatotropin was first meant to help to support the 
growing world population and increasing demands of food, reducing also environmental 
impact of food production 
[2]
. However, it soon became a tool to increase profit as it 
happened to many other veterinary drugs and/or growth promoters, and in many cases it 
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has been used without considering animal welfare 
[6-8]
. Recombinant bovine somatotropin 
(rbST) can be used to enhance milk production in cows and in other dairy ruminants as 
sheep, goats and buffaloes 
[9]
. Additionally, its potential as growth promoter has been also 
demonstrated in cattle and even in aquaculture 
[10,11]
. The administration of rbST is 
permitted in several countries including the US, Brazil and Mexico, among others, while 
it has been banned in others, for instance Canada, Australia and New Zealand. In 1999, 
the European Union (EU) decided to definitively ban possible use of recombinant bovine 
somatotropin (rbST) in the European Members invoking animal welfare reasons, but also 
the impact on the European milk policy and consumer fears 
[12]
. Besides, an increase of 





Each time a new piece of legislation is adopted to ban or regulate a specific drug or 
veterinary treatment, a new analytical need is born to monitor its (ab)use. Additionally, 
the control of veterinary drug residues in food of animal origin is essential to protecting 
the consumers and, where necessary, verifying its compliance with the established 
maximum residue limits. A good example is a relatively recent scandal that took place in 
Spain in 2013, when a hundred of people were involved in a crime against public health 
and animal abuse due to illegal somatotropin treatments. According to the authorities, 
many farmers were administering rbST to cows as a common practice, using commercial 
injections from Mexico that were introduced illegally in the country. Clearly, 
recombinant bovine growth hormone is included among the current challenges of 
European residue control plans 
[14]
. On the other hand, in countries where the rbST use is 
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permitted it is easy to find in the market products labelled as rbST-free, especially in 
dairy. In these cases, it might be necessary to check the truth of this indication on the 
labelling concerned. In this sense, novel analytical platforms based in liquid preparations 
and in liquid chromatography represent up-to-date technologies which allow very low 




The present review focuses on the existing liquid-based methodology to monitor (r)bST 
(extraction, separation, detection,…), providing a selection of the most relevant works 
published in the last 5 years (2012  2017). The study is meant to be a useful guide for 
future analysts and/or laboratories willing to monitor this hormone. The physical-
chemical properties of bST and different recombinant versions are also summarized. 
 
2. OPTIONS IN LIQUID EXTRACTION FOR (R)BST ANALYSIS 
Liquid extractions and preparative steps using different solvents (precipitation, pH 
adjustment, dilutions, washings, etc.) are broadly and worldwide applied in analytical 
laboratories. Also, some chemical reactions as digestions, molecule cleavages and 
derivatizations, require a liquid medium to be performed. With this regard, the physical-
chemical properties of both the solvent and the target analyte are very important factors 
and must be evaluated carefully to achieve the desired goal of the analytical method.  
 
2.1. Physical-Chemical Properties Of Natural And Recombinant Bst 
Pituitary growth hormone is a protein hormone with a molecular weight of about 22 kDa 
and substantial species-specific variations 
[16,17]
. For instance, bovine growth hormone 
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differs very substantially from human or porcine hormones (from at least 10% to 40% of 
all residues), but is very similar to the ovine version 
[18]
. Bovine GH (bGH or bST) is a 
single-chain polypeptide of 191 amino acids, with two disulphide bridges between the 
amino acids cysteine at positions 53 and 164, and positions 181 and 189 of its primary 
structure. It shows two transcriptional variants in its natural form where valine and 
leucine are found in an approximate ratio 1:2 at residue 127 due to an allelic 
polymorphism 
[18]
. The frequencies of leucine127 and valine127 bST gene alleles are not a 
constant and differ between major dairy breeds but leucine can be considered the most 
abundant 
[19]
. When purified from pituitary extracts, bGH shows a complex heterogeneity 
due to these naturally occurring transcriptional variations, but also because of 
translational and post-translational modifications 
[17,18]
. The co-translational 
modifications result in two possible aminoacyl N-terminal residues, alanine (191 amino 
acids) and phenylalanine (190 amino acids), in approximately equimolar quantities (about 
0.5 mole of each of them per mole of protein). This means that half of the polypeptide 
chains lack the N-terminal alanine residue. A third possibility with N-terminal 
methionine, present with less frequency, has been also described but data concerning its 




The genetically engineered versions, the so-called recombinant bovine somatotropins, 
have been produced with different N-terminal variants by different companies, all with 
full biological activity in vivo. Up to date, four analogues of bovine somatotropins, i.e. 
somagrebove, sometribove, somavubove, and somidobove, have been produced by 
recombinant-DNA techniques (see details in Table 1). Boostin® or Hilac® from LG 
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LifeSciences (South Korea) and Lactatropin® (Lactotropina® in Latin America) or 
Posilac® from Elanco (USA) are the two most famous and widespread products 
containing recombinant bST for use in dairy cattle. The difference between the most 
abundant endogenous form and the recombinant bST contained in Posilac® and/or 
Lactatropin® doses (sometribove) is only one extra amino acid at the amino-terminal 
end, methionine. In contrast, Boostin® (or Hilac®) contains a recombinant analogue 
(somavubove, developed by The Upjohn Company, USA) with a sequence virtually 
identical to the natural pituitary protein with terminal alanine. The structural formula 
(amino acid sequence) of the naturally occurring hormone and the different existing 
(r)bSTs are shown in Figure 1. Somagrebove and somidobove have been rarely used and 




As regard rbST solubility, this is extremely dependent on pH, being the minimum 
solubility between 7 and 8. Similarly to its natural counterpart, it is soluble in weak acidic 
or alkaline buffers, insoluble in water, alcohol, acetone, benzene, and chloroform 
[1]
. 
Temperature has been noted to have very little effect on this solubility, ranging from 8.1 
mg/mL at 5 ºC to 11.7 mg/mL at 37 ºC in pH 7.4 
[22]
. Also, ionic strength has a profound 
effect on the pH-solubility profile. High-pH buffer solutions, between pH 9 and 12, have 
been used to maintain solutions since the isoelectric point of bST is around 7.4. Hence, a 
common used solution consists of 0.025 M NaHCO3 and 0.025 M Na2CO3 at pH 9.4 
[23]
. 
Conformational changes may occur under acidic conditions, resulting in significant 
precipitation, as a partial unfolding of rbST molecule can be induced by acid pH. The 
hydrophobic aggregate formed from precipitation of rbST has an extremely low 
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solubility, and hence it is very important to avoid this phenomenon 
[22]
. It is also 
important to consider the occurrence of cross-linking and hydrolysis reactions produced 
on lyophilized rbST, both sensitive to the pH of the solution before lyophilization. 
Typical of many proteins, this hormone is susceptible to undergo significant precipitation 
induced by agitation 
[22]
. Also, it should be noted that lyophilized bovine somatotropin is 




2.2. Liquid-Based Extractions And Preparative Solutions 
The determination of recombinant somatotropin in animals has been mainly carried out 
through biomarker-based approaches, and only a relatively low number of methods to 
directly detect the hormonal compound have been developed so far 
[25]
. The main 
challenge during method development for rbST analysis has been sample preparation, 
due to both the complexity of the biological samples and the very low levels of this 
protein in the treated animal. Preparative steps to determine rbST usually include 
different buffers to adjust sample pH and/or provoke precipitation of the hormone. Later, 
the detection method marks the steps to be followed, including for instance solid phase 
concentration and tryptic digestion of the target protein. 
 
In Table 2, a summary of the liquid-based methods developed to extract bovine 
somatotropins from different matrices is presented, including works published in the last 
five years (2012 – 2017). Protein purification procedures usually take advantage of the 
changes in solubility of the target protein, altering the solvent conditions to force its 
precipitation 
[26]
. As it can be observed in this table, the adjustment of sample pH with 
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phosphate buffer at pH~7 is a prerequisite to precipitate proteins with ammonium sulfate 
((NH4)2SO4). Firstly, somatotropins in aqueous solution (serum, milk) are lead to 
aggregation and precipitation by approaching the pH to their isoelectric point, where they 
are less soluble as they have zero net charge. This tendency to interact and aggregate in 
the solution is promoted by adding high salt concentrations. To this end, (NH4)2SO4 is 
used as the salt of choice, since it is very soluble and relatively cheap. This salt is also 
very stabilizing to protein structure and it preserves its activity 
[26]
. This “isoelectric 
tandem salting-out” precipitation technique was successfully applied for the 
determination of (r)bST in trout and buffalo serum, in the first case using very little 
amount of serum (only 50 µL), followed by a SPE clean-up with C4 cartridges and LC-
MS determination 
[27,28]
. The misuse of recombinant growth hormones in equine sports is 
also possible, especially due to the existence of possible cross-species applications to 
horses (GHs from other species have shown being biologically active in horses). In 2016, 
Wong et al reported a multiplexed mass spectrometric method for the simultaneous 
detection of three recombinant hormones in equine plasma: recombinant equine GH 
(reGH), recombinant human GH (rhGH) and recombinant porcine GH (rpGH) 
[29]
. They 
used polyethylene glycol (PEG) 6000 and ammonium acetate at pH 5 (instead of 
phosphate buffer), in combination with ammonium sulfate precipitation. Due to the lower 
isoelectric point of recombinant human GH in in comparison to the other somatotropins 
included in this method, buffer and (NH4)2SO4 were used at a lower pH than in other 




Regardless of the first precipitations step, a second solid phase extraction (SPE) is usually 
performed, with very few exceptions, before tryptic digestion and LC-MS determinations 
[27-29]
. In this sense, some authors have reported that the best SPE performance is 
achieved with a C4 matrix active group, with particle size of 20 μm and 300 Å pore size 
[28]
. They reported recoveries for somavubove and sometribove in buffalo samples around 
30%, including the recombinant porcine ST used as internal standard. In some cases, the 
obtained SPE eluate may be further cleaned up by chloroform/methanol precipitation 
before digestion procedures 
[29]
. In contrast to the rest, Smits et al developed in 2015 an 
interesting method of immune-affinity enrichment on monolithic micro-columns to 
extract rbST from serum of treated animals 
[30]
. A polyclonal antiserum against rbST 
(sometribove) was obtained and in-house purified, to be applied to the monolithic micro-
columns. With the monoliths contained inside pipet tips, and these tips placed on a 
multichannel automated pipette, the authors achieved a very effective extraction in a 
process that last 4.5 hours but works practically alone. The reported recovery of this 
immuno-enrichment was of approximately 50 % at concentrations up to 10 ng mL
-1
, 
dropping to a half or less for the highest concentrations due to a saturation of the 
monolithic tips. In this work, after tryptic digestion and not before, the protein fragments 
were concentrated using non-polar polymeric SPE catridges and analyzed then with 
UHPLC-MS/MS. 
 
Similarly to animals, synthetic human growth hormone (rhGH) is commercially produced 
for pharmacological treatments of growth-related diseases in humans 
[31]
. However, it is 
also suspected of being misused in sports for performance improvements in athletes and 
 
 11 
as such it is prosecuted by anti-doping agencies (World Anti-Doping Agency website). 
Once more, the similitude between this drug and its natural version complicates the 
detection of administration in sportspeople. In this context, the second most abundant 
variant of GH, containing fewer amino acids than the most abundant one (176 amino acid 
residues versus 191 amino acids) and existing at a constant ratio with respect to the other, 
can be used to demonstrate abuse. In 2015, Such-Sanmartín et al reported an interesting 
alternative method to purify and detect both human GH variants in plasma that could be 
transferred to the animal field 
[32]
. With the Mass Spectrometry Immuno-Assay (MSIA) 
that the authors propose, no protein precipitation is required; instead, GH is purified from 
plasma using an antibody-based approach providing maximum sensitivity. Nevertheless, 
the precipitation based method remains as a promising tool, and it also can be scaled up 
for quantification of additional low-mass proteins that are non-specifically extracted in 




2.2.1. Enzymatic digestions of (r)bST 
Tryptic digestion of rbSt is sometimes required for identification purposes, as in LC-MS 
methods or for amino acid sequence elucidations. Liquid chromatography demands a 
preliminary enzymatic digestion of the hormone because this simplifies the 
chromatography and allows focusing the subsequent detection on only one small 
sequence of the protein. Common digestion reagents include NH4HCO3 or (NH4)2CO3 
buffers, EDTA, acetonitrile and trypsin. Smits et al reported the necessity of a first pH 
adjustment to 8-8.5 with hydrochloric acid, and addition of DL-dithiothreitol (DTT) to 
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reduce sulphur bridges. After incubation in this solution for 30min at 37°C, 




The digestion of somatotropin with trypsin is usually performed at 37ºC overnight or 16 
hours 
[27,28]
, even though some authors have reported that 1 hour is enough 
[30]
. The 
reaction must be then stopped by acidification with a quenching solution of for instance 
formic acid and water before instrumental analysis. Trypsin has been the enzyme of 
choice for digestion of bovine somatotropin so far. However, Such-Sanmartín et al tried 
both porcine trypsin and S. aureus V8-protease (endoproteinase Glu-C) for digestion of 
human plasma samples concluding that the latter is more adequate to generate individual 
and specific peptides of human growth hormone variants 
[32]
. If this is also true for animal 
somatotropins is a fact that remains to be seen. 
 
2.2.2. Extraction of (r)bST from commercial formulations 
The different formulations developed for rbST administration in animal husbandry have 
been aimed mainly at achieving long-releasing (and consequently, long-acting) options 
[23]
. As discussed previously (section 2.1), like many other proteins somatotropin shows 
pH-dependent solubility and stability, tendency to aggregate, heat and enzyme lability 
and rapid in vivo clearance. These properties make formulation design difficult. The 
administration of this hormone has to be done by injection, since it would be digested if 
added to feed, like any other protein. To avoid daily injections, and make its commercial 
use feasible in large farms, a long-release formula was firstly developed by Monsanto, 
consisting of the zinc salt of sometribove, suspended in food-grade vegetable oil (sesame 
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oil aluminum monostearate). This formula is injected under the skin, subcutaneously, and 
it would protect rbST from tissue proteases, preventing rapid degradation and allowing a 
prolonged release of the drug. Also, this kind of formula (emulsion instead of solution) 
protects somatotropin from moisture, thus helping assure chemical and physical stability 
[23]
. Apart from rbST, Boostin® contains vitamin E and lecithin. Lactatropin® only 
declares zinc sometribove in its composition (equivalent to 500 mg of bovine 
somatotropin). Posilac®, registered trademark of Monsanto Company, contains a sterile 
sometribove zinc suspension. All current commercial products are prolonged-release 
injectable formulations in single-dose syringes, each containing 250 or 500 mg of rbST, 
capable of maintaining a sustained and “active-effective” level of hormone in the animal 
for about 14 days. 
 
It may not be easy to obtain pure standard of rbST for research purposes, especially in 
Europe, as manufacturers are usually reluctant to sell their standards of recombinant 
variants due to the European ban of rbST use. Also because doubts may arise in relation 
to the recombinant version used in a specific formulation, it seems a good option to 
obtain the reference standard from the actual commercial dose. In this context, it is useful 
to have a reference method to extract the hormone from commercial formulations. Chang 
et al described a non-denaturing method in 1997 to extract rbST from oleaginous vehicles 
[21]
. The protocol consisted on a simple extraction with a buffer solution of borate-
ethylenediaminetetraacetate (EDTA) at pH 9.5 in a VanKel dissolution system, at 40°C 
for 3 hours. The recovery of rbST, in their case somidobove, was on average more than 
90%. Recently, Castigliego et al described a very simple and straightforward method to 
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isolate rbST (somavubove) from slow-release preparations, i.e. Boostin® 
[28,33]
. The 
reported method consists of two successive carbonate buffer (pH 9.6) additions, 
vortexing and cool centrifugation, in order to separate the grease layer from the protein 
solution. The protein solution concentration can be measured by spectrophotometry (280 
nm) and further evaluated by SDS-PAGE.  
 
3. SEPARATION OF (R)BST USING LIQUID CHROMATOGRAPHY 
As in the case of extraction methods, physical-chemical properties also have to be taken 
into account when developing a separation step. The separation (r)bST using liquid 
chromatography demands a preliminary enzymatic digestion of the hormone using 
trypsin, which has been discussed in the previous subsection 2.2. This step simplifies the 
chromatography and allows focusing the detection on the N-terminal part of the protein. 
Actually, the N-terminal peptide is sufficient (and necessary) to discriminate between 
natural somatotropin and its recombinant counterpart. Besides, mass spectrometry is also 
more sensitive and simple than using the whole protein for the analysis.  
 
Table 3 shows the most recently published works (2012-2017) using liquid 
chromatography to separate rbST (peptides after tryptic digestion) in biological samples. 
As it can be observed in this table, the preferred column packing sorbents for reversed 
phase chromatography are C18 and C8. The UHPLC separation of N-terminal rbST 
peptides from trout serum performed by Rochereau-Roulet et al was based on a gradient 
elution in a C18 column, using a binary mobile phase composed of acetonitrile and water 
with 0.1% formic acid 
[27]
. Smits et al developed a method for bovine serum using also 
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UHPLC with a C18 column, acidified water and acetonitrile, and in this case with a 
slightly smaller particle size 
[30]
. Similarly, Wong et al successfully separated the 
proteotypic peptides of four recombinant GH (recombinant equine, porcine, human and 
chicken growth hormones) and natural equine GH (eGH) using a nano-UPLC system 
equipped with a C18 column designed specifically for reversed-phase separation of 
peptides and proteins 
[29]
. Once more, the selected liquid phase was a combination of 
acidified water and acetonitrile. Peptides were detected by high resolution mass 
spectrometry in positive ESI mode. For human growth hormones, this same combination 
of C18 particles and binary mobile phase has been reported 
[32]
. In a method to determine 
(r)bST peptides present in buffalo serum, Castigliego et al combined a C8 column with a 
UHPLC binary system and a HPLC quaternary pump, in order to discard both head and 
tail of the chromatographic runs with the aid of a divert valve 
[28]
. The HPLC pump 
worked with an isocratic combination of pure methanol and water, and UHPLC worked 
in gradient mode with acidified acetonitrile/methanol (80/20, v/v) and acidified water. 
 
3.1. Considerations When Using Mass Spectrometry (LC-MS) 
The unequivocal detection N-terminal peptides of (r)bST is usually carried out with triple 
quadrupole mass spectrometers working in multiple reaction monitoring (MRM) mode or 
high resolution mass spectrometers (HRMS), with positive electrospray ionization 
[27,28,30,34,35]
. In these cases, the determination of only a part of the whole protein of 
somatotropin requires a digestion step prior its analysis, using the procedures already 
reported in section 2.2.1. The obtained N-terminal fragments are expected to differ 
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between natural bovine somatotropin and its recombinant versions (see Figure 1 for 
details) and are used for unequivocal identification.  
 
As it was described in section 2.1, bovine somatotropin shows natural heterogeneity in its 
amino acid sequence due to transcriptional, translational and post-translational variations 
[18]
. The main heterogeneity has been detected at two positions: the N-terminus and 
residue 127. As it is shown in Figure 1, these modifications include two possible residues 
at position 127 and two N-terminal residues, phenylalanine (NH2-Phe1-Pro2…) and 
alanine (NH2-Ala1-Phe2-Pro3…). Clearly, for somidobove and somagrebove, marked 
differences exist between their NH2 terminus and those of natural somatotropin variants. 
These differences simplify the development of analytical methods to monitor its use in 
bovine animals. However, for the two main rbST forms available on the market, 
sometribove and somavubove, the situation is not as simple because their structural 
differences diminish or even disappear. Sometribove, also known as methyonil-rbST, has 
an extra methionine compared to the phenylalanine pituitary variant, or a substitution if 
compared to the alanine one. The peptide fragments can be distinguished using mass 
spectrometry, and for this reason the analytical methods developed so far have targeted 
this recombinant version. However, the other form, somavubove, which is also 
widespread for dairy cattle, is identical to one of the variants of pituitary bovine 
somatotropin: bST with N-terminal alanine. For this reason, no methods for somavubove 
detection in bovine animals have been developed so far. It is technically impossible to 
distinguish somavubove, commercially known as Boostin® or Hilac®, from pituitary 
bST in bovine serum and/or milk. The only LC-MS method found in the literature has 
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been recently developed by Castigliego et al, not for cows but for buffalos 
[28]
. In this 
context, it seems pertinent to develop effect-based analytical methods including 
biomarkers, quantitative ratios, profiling and other indirect techniques that could result in 




 measurements for the detection 
of somatotropin has not been reported yet.  
 
4. OTHER LIQUID APPLICATIONS AND INDIRECT DETERMINATIONS OF 
RBST 
Flow cytometry is a biophysical technique employed routinely in many scientific fields 
and for different purposes, including cell counting, immunoassays and protein isolations. 
The operation of flow cytometers relies on an isotonic liquid or fluid called sheath fluid. 
This liquid flows in a laminar way with cells or particles in suspension, carrying and 
aligning them so that they can pass individually through a measuring point 
[36]
. These 
liquid-based systems have demonstrated its applicability also to monitor somatotropin 
abuse in cattle. A multiplex flow cytometric immunoassay capable of discriminating 
between milk from rbST-treated and untreated animals was developed by Ludwig et al in 
2012 
[37]
. The method was based on the detection of anti-rbST antibodies in raw milk. 
The authors stated that pooled tank milk samples should be preferred to minimize the 
problem of non-responding cows in the farm. A similar approach was reported a year 
later by the same team, using a flow cytometric immunoassay to profile various 






Other liquid-based platforms include lab-on-a-chip devices, which integrate microfluidic 
systems which allow solvent-saving, a reduced time of assay and lower cost of 
equipment. These analytical methods have also been used as an alternative to more 
expensive platforms in rbST abuse monitoring 
[39-41]
. A microfluidics system coupled to a 
smartphone enabled to build a portable immunoassay platform capable of detecting rbST 
biomarkers in milk, including different antibodies and also positive and negative controls 
[42]
. This smartphone-based protein microarray requires different buffers and solutions to 
function. The analyst is able to analyze the images instantly on the phone thanks to 
Quantum dots, built-in UV LEDs and a custom-developed Android application. 
 
Enzyme-linked immunosorbent assays (ELISA) are very simple routine procedures based 
on the binding antigen-antibody in a liquid medium. This procedure has been used to 
measure the responsiveness of the animal to rbST treatments, using preferably milk and 
serum as target matrices. A new ELISA based on an acid-stripping procedure was 
developed very recently to measure buffalo serum and milk responsiveness towards rbST 
[33]
. Antibody production for these assays is a complicated task due to the high degree of 
homology of rbST, particularly sometribove and somavubove, and bST. A novel strategy 
for the production of specific polyclonal antibodies for methyonil-rbST based on the use 
of the full-length protein, a N-terminus fragment and a multiple antigen peptide 
[43]
. The 
polyclonal antibodies exhibited a great binding ability towards rbST in a competitive 





Despite being banned in several countries as the European Union members, Australia or 
New Zealand, among others, the use of recombinant bovine somatotropin in cattle is 
quite likely, considering the significant worldwide livestock industry. Also, the potential 
existence of fraudulent labelling of rbST-free dairy products is not monitored in those 
countries where its use is permitted, presumably due to the absence of analytical options. 
It is curious that only one confirmatory method for somatotropin administration in bovine 
animals has been published in the last five years. The present review can serve as a 
practical guide to promote the development of analytical methods to detect rbST use and 
abuse. Liquid-based strategies constitute versatile and straightforward options for this 
task, including protein precipitations, liquid extractions and hormone digestions, coupled 
to liquid chromatography and mass spectrometry determination. 
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Table 1. Summary of the existing pituitary and recombinant bovine somatotropins, 


























NH2 – Ala1 – Phe2
 


















































199 NH2 – Met1 – Phe2 – Pro3 – 
Leu4 – Asp5 – Asp6 – Asp7 – 
















*NH2 – residue1 – residue2– (amino acids nomenclature, Ala: alanine, Phe: 
phenylalanine, Met: methionine, Pro: proline, Leu: leucine, Asp: aspartate, Lys: lysine, 
Gln: glutamine, Leu: leucine, Val: valine). 
†
Source: U.S. National Library of Medicine (ChemIDplus); molecular weight of natural 







Table 2. Options for liquid extraction and preparative steps for (r)bST analysis in animal 
matrices reported in the last five years (2012-2017). 
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Table 3. Separation of (r)bST present in animal matrices using liquid chromatography, 
including methods reported in the last five years (2012-2017). 










BEH C18 good peak shape; 
elution < 3 minutes 

























head and tail of 
HPLC runs are 
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pump + UHPLC 
binary pump 
LLOD 0.25 ng/ml 







Figure 1. Primary structure of pituitary and recombinant bovine somatotropins. 
 
